Related to Advaxis Taps Karolinska Researcher to Test Immunotherapies Against Allergies

• FDA Hits Merck & Co. with Double Whammy for Gardasil Label Extensions
  
• Celldex Licenses Cholera and ETEC Vaccine Programs to Vaccine Technologies
  
• Pfizer to Pony Up $68B for Wyeth
  
• Novavax to Use Vivalis’ Duck Embryonic Stem Cell Line for Vaccine Production
  
• WHO Gains Access to Schering-Plough Manufacturing Technology for Flu Vaccines
  
• PDS to Use Merck Eprova's Cationic Lipid to Enhance Preclinical Compounds
  
• Fraunhofer CMB and iBioPharma Pocket $12M for Accelerated Manufacture of Vaccines
  
• PATH Malaria Vaccine Initiative Allies with VGX
  
• Xcellerex, Dowpharma, Biopharm, and deltaDot Win $11M Technology Development Contract
  
• La Jolla Institute to Test IVT’s Delivery Platform with Infectious Disease Candidates
  
• Malfunction of the Respiratory Epithelium Implicated as Cause for Allergy
  
• Adjuvant IL-7 Boosts Vaccine-Induced Immune Response to Tumors
  
• Sanofi Pasteur's Flu Vaccine Manufacturing Plant Gets FDA Nod
  
• ImmuneRegen Taps University of Pittsburgh Scientist to Work on Preclinical Flu Vaccine
  
• FIT Biotech and ImmunoVaccine Ally to Enhance HIV Vaccine Candidate
  
• Simcere Pays $28.5M for Majority Stake in Chinese Vaccine Company
  
• CellDex to Buy CuraGen in Deal Valued at $94.5M
  
• Biovest’s Stock Value Triples with Phase III Data on Lymphoma Vaccine
  
• NIH to Evaluate Novavax Vaccine Candidate for Novel H1N1 Strain
  
• Novartis Vaccines Institute Gets Roughly $7M to Develop Bivalent Typhoid Vaccine